MENU
JUN 17, 2020 1:30 PM PDT

Harnessing the power of synthetic biology to combat COVID-19

Sponsored by: Codex DNA
Speakers
  • CTO
    Biography
      Dan Gibson is the CTO of Codex DNA. He oversees Codex DNA's world-class R&D team and sets the technical vision for the company. Dan is the inventor of the Gibson Assembly® method, which has over 4,000 citations in scientific literature, and is regarded as a luminary in the field of synthetic biology. He and his team are consistently pioneering new ways to advance the field of synthetic biology and pushing boundaries in the disciplines of personalized medicine, antibody therapy development, agriculture and industrial materials. Dan and his team formed the foundational technology that drives the BioXp 3200TM and the Digital to Biologic Converter (DBC) and continue to develop new, cutting edge tools for whole genome design, synthesis and assembly, and activation. To learn more about the work of Dan's team and the DBC view his 2018 Ted talk. Prior to Codex, Dan was Vice President of DNA Technology at Synthetic Genomics where he spearheaded efforts to develop a rapid approach for producing viral genes used in pandemic vaccine production in 2013, and he led the team that developed the first synthesized minimal cell in the world in 2016. Prior to Synthetic Genomics Dan spent more than six years at the J. Craig Ventner Institute where he co-led the team that constructed the first synthetic bacterial genome in 2008 and the first synthetic cell in 2010. Dr. Gibson earned his Ph.D. in Molecular Biology from the University of Southern California. Before earning his Ph.D., he earned his Bachelor's degree in Biological Sciences from the State University of New York at Buffalo.
    • Staff Scientist
      Biography
        Krishna Kannan is a Staff Scientist at Codex DNA. He received his PhD from the University of Illinois at Chicago. Over the past few years, Krishna has worked closely with Synthetic Biology experts at JCVI and SGI, and contributed to the development of synthetic cell with a minimal genome and the digital-to-biological converter. He recently completed the de novo synthesis of the SARS-CoV-2 genome. Krishna's research has been published in top tier journals such as PNAS, Cell, Science and Nature Biotechnology. In his current role, Krishna is involved in Codex DNA's new product development.
      • Sr. Scientist
        Biography
          Katie Lyons is a molecular and synthetic biologist at Codex DNA. She was responsible for adapting the synthetic gene assembly process onto the BioXpTM , the first instrument capable of "printing" genes. Katie has worked in protein and RNA vaccine engineering, molecular diagnostics at the San Diego Zoo Institute for Conservation Research and is currently a Senior Scientist at Codex DNA.

        Abstract

        In his 2018 TED talk “How to build synthetic DNA and send it across the internet,” Dr. Dan Gibson highlighted a unique synthetic biology approach for fighting pandemics such as SARS, H1N1, and Ebola. Two years later, the unmitigated threat of COVID-19 has affected more than 2 million people to date and is expected to impact millions more.

        The current outbreak demands innovative synthetic biology solutions to develop vaccines, diagnostics, and treatments. Moreover, the identified number of genome variants of SARS-CoV-2 thus far is likely to impact future efforts towards the prevention, detection, and treatment of the disease. Solutions are needed to rapidly construct the SARS-CoV-2 genome, genome variants, genome parts, and vaccine / therapeutic scaffolds to treat and prevent current and future strains of the virus.

        Join us as we discuss our approach to completing the world’s first on-demand synthesis of the SARS-CoV-2 genome using a commercially available, automated DNA assembly and cloning instrument — the BioXp™ 3200 system. This solution accelerates vaccine, diagnostic, and treatment development pipelines by enabling rapid synthesis of up to 32 individual gene fragments in a single overnight run. We will also discuss the hierarchical assembly of the full-length SARS-CoV-2 genome and its potential applications.


        Show Resources
        You May Also Like
        SEP 10, 2020 9:00 AM PDT
        C.E. CREDITS
        SEP 10, 2020 9:00 AM PDT
        Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
        C.E. CREDITS
        This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
        JUN 17, 2020 1:30 PM PDT
        C.E. CREDITS
        JUN 17, 2020 1:30 PM PDT
        Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
        NOV 18, 2020 8:00 AM PST
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        C.E. CREDITS
        NOV 18, 2020 8:00 AM PST
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
        MAY 08, 2020 10:00 AM PDT
        C.E. CREDITS
        MAY 08, 2020 10:00 AM PDT
        DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
        OCT 29, 2020 6:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        C.E. CREDITS
        OCT 29, 2020 6:00 AM PDT
        Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
        Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
        Loading Comments...
        Show Resources
        Attendees
        • See more